About Human Prostaglandin D2 Receptor (PTGDR/DP1 Receptor) Stable Cell Line

Prostaglandin D2 Receptor (PTGDR), also known as DP1 receptor, is a Class A G protein-coupled receptor (GPCR) that serves as a primary receptor for prostaglandin D2 (PGD2), a bioactive lipid mediator produced by mast cells, eosinophils, dendritic cells, and other immune cells during inflammatory and allergic responses. PTGDR is widely expressed in immune cells, airway tissues, vascular endothelium, central nervous system tissues, and other organs where it regulates inflammatory signaling, immune function, vasodilation, and allergic reactions. Upon activation by PGD2, PTGDR primarily couples to Gs proteins, stimulating adenylate cyclase activity and increasing intracellular cAMP levels, leading to modulation of downstream signaling pathways involved in inflammation and immune regulation.

PTGDR plays important roles in allergic diseases, asthma, rhinitis, inflammatory disorders, sleep regulation, and immune cell function. Activation of PTGDR can influence vascular permeability, smooth muscle relaxation, cytokine production, and leukocyte activity. The PGD2-DP1 signaling pathway has been implicated in respiratory diseases, allergic inflammation, neuroinflammatory processes, and immune-mediated disorders. Consequently, PTGDR has emerged as an important therapeutic target for the development of treatments for asthma, allergic diseases, inflammatory conditions, and immune dysfunction.

eEnzyme's Human PTGDR Stable Cell Line provides a reliable and reproducible cellular platform for investigating DP1 receptor pharmacology and signaling mechanisms. The cell line enables quantitative assessment of agonists, antagonists, and novel receptor modulators through cAMP assays, reporter gene assays, and other GPCR functional screening platforms. Researchers can utilize this stable cell line for receptor characterization, compound profiling, potency determination, lead optimization, and high-throughput screening applications supporting allergy, immunology, and inflammation-focused drug discovery programs.

Applications of the PTGDR Stable Cell Line

• PTGDR (DP1) receptor pharmacology studies
• Prostaglandin D2 signaling investigations
• Agonist and antagonist screening
• Asthma and allergic disease research
• Inflammation and immunology studies
• Respiratory disease drug discovery
• cAMP and GPCR functional assays
• High-throughput screening applications

Biological Significance of PTGDR

PTGDR is an important mediator of prostaglandin D2 signaling and contributes to the regulation of immune responses, allergic inflammation, and tissue homeostasis. Activation of DP1 receptors stimulates cAMP-dependent signaling pathways that influence immune cell behavior, vascular function, cytokine production, and inflammatory responses. In respiratory diseases, PTGDR signaling contributes to the complex regulation of airway inflammation and allergic reactions. The receptor has also been implicated in sleep regulation, neuroprotection, and modulation of central nervous system functions through prostaglandin-mediated signaling pathways. Because of its involvement in allergy, asthma, inflammation, and immune regulation, PTGDR remains an important target for pharmaceutical research and GPCR-focused drug discovery. The PTGDR Stable Cell Line provides a valuable tool for studying prostaglandin receptor biology and advancing the development of novel therapeutics targeting allergic and inflammatory diseases.